sevelamer hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., Usa. The primary component is Sevelamer Hydrochloride.
| Product ID | 68462-447_2cd6512f-0edd-4a30-a4fa-aa996038633c | 
| NDC | 68462-447 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | sevelamer hydrochloride | 
| Generic Name | Sevelamer Hydrochloride | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2019-02-08 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA204724 | 
| Labeler Name | Glenmark Pharmaceuticals Inc., USA | 
| Substance Name | SEVELAMER HYDROCHLORIDE | 
| Active Ingredient Strength | 800 mg/1 | 
| Pharm Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2019-02-08 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA204724 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-02-08 | 
| Marketing Category | ANDA | 
| Application Number | ANDA204724 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2019-02-08 | 
| Ingredient | Strength | 
|---|---|
| SEVELAMER HYDROCHLORIDE | 800 mg/1 | 
| SPL SET ID: | 2cd6512f-0edd-4a30-a4fa-aa996038633c | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0955-1048 | Sevelamer Hydrochloride | Sevelamer Hydrochloride | 
| 60687-449 | Sevelamer Hydrochloride | Sevelamer Hydrochloride | 
| 68462-446 | sevelamer hydrochloride | sevelamer hydrochloride | 
| 68462-447 | sevelamer hydrochloride | sevelamer hydrochloride | 
| 70748-172 | Sevelamer hydrochloride | Sevelamer hydrochloride | 
| 70748-173 | Sevelamer hydrochloride | Sevelamer hydrochloride | 
| 58468-0021 | Renagel | sevelamer hydrochloride |